C07J 7/0025
Substituted in position 16
Official title: {substituted in position 16}
C07J7/0025 (Substituted in position 16) appears on 26 US grants and 19 published applications in this corpus.
Search patents in C07J- Granted patents
- 26
- Published applications
- 19
- Assignees
- 19
- Inventors
- 81
- Latest grant
- 12 Nov 2024
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 2 | 0 |
| 1977 | 1 | 0 |
| 1978 | 0 | 0 |
| 1979 | 1 | 0 |
| 1980 | 2 | 0 |
| 1981 | 0 | 0 |
| 1982 | 1 | 0 |
| 1983 | 0 | 0 |
| 1984 | 1 | 0 |
| 1985 | 2 | 0 |
| 1986 | 2 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 0 | 0 |
| 1991 | 1 | 0 |
| 1992 | 1 | 0 |
| 1993 | 1 | 0 |
| 1994 | 0 | 0 |
| 1995 | 0 | 0 |
| 1996 | 0 | 0 |
| 1997 | 1 | 0 |
| 1998 | 1 | 0 |
| 1999 | 1 | 0 |
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 1 | 1 |
| 2003 | 0 | 1 |
| 2004 | 0 | 2 |
| 2005 | 0 | 0 |
| 2006 | 0 | 1 |
| 2007 | 1 | 0 |
| 2008 | 0 | 0 |
| 2009 | 0 | 0 |
| 2010 | 0 | 0 |
| 2011 | 0 | 0 |
| 2012 | 0 | 0 |
| 2013 | 0 | 0 |
| 2014 | 0 | 0 |
| 2015 | 0 | 1 |
| 2016 | 0 | 1 |
| 2017 | 1 | 0 |
| 2018 | 0 | 0 |
| 2019 | 2 | 3 |
| 2020 | 0 | 1 |
| 2021 | 0 | 1 |
| 2022 | 1 | 2 |
| 2023 | 0 | 1 |
| 2024 | 2 | 1 |
| 2025 | 0 | 3 |
By publication year. Applications have been published since 2001.
Subgroups
Granted patents
Recent patents
- Steroid derivative regulators, method for preparing the same, and uses thereof12 Nov 2024US 12,139,508 B2Jiangsu Hansoh Pharmaceutical Group Co., Ltd.
- C7, C12, and C16 substituted neuroactive steroids and their methods of use28 May 2024US 11,993,628 B2Sage Therapeutics, Inc.
- Quantitative profiling of progesterone metabolites for the prediction of spontaneous preterm delivery22 Mar 2022US 11,280,795 B2Indiana University Research and Technology Corporation
- Non-hormonal steroid modulators of NF-κβ for treatment of disease5 Nov 2019US 10,464,967 B2ReveraGen BioPharma, Inc.
- Methods for preparation of bile acids and derivatives thereof17 Sep 2019US 10,414,791 B2Intercept Pharmaceuticals, Inc.
- Non-hormonal steroid modulators of nf-kappa beta for treatment of disease8 May 2025US 2025/0145657 A1ReveraGen BioPharma, Inc.
- C7, c12, and c16 substituted neuroactive steroids and their methods of use20 Mar 2025US 2025/0092084 A1Sage Therapeutics, Inc.
- Steroid derivative regulators, method for preparing the same, and uses thereof13 Feb 2025US 2025/0051387 A1Jiangsu Hansoh Pharmaceutical Group Co., Ltd.
- Compositions and methods for treating cns disorders28 Mar 2024US 2024/0101592 A1Sage Therapeutics, Inc.
- C7, c12, and c16 substituted neuroactive steroids and their methods of use19 Jan 2023US 2023/0021308 A9Sage Therapeutics, Inc.
Most cited
By later US patents
- Chemical compounds60US 4,192,871 AGlaxo Laboratories Limited · 1980
- 3-Keto-19-nor-.DELTA.4,9-steroids39US 4,477,445 ARoussel Uclaf · 1984
- 5 .alpha.-pregnan-20-ones and 5-pregnen-20-ones and related compounds24US 5,175,154 AResearch Corporation Technologies, Inc. · 1992
- 3-Keto-19-nor-.DELTA..sup.4,9 -steroids22US 4,540,686 ARoussel Uclaf · 1985
- Pharmaceutical compositions having appetite suppressant activity17US 6,376,657 B1Csir · 2002